Commentary: European Medicines Agency recommends approval of a broadly protective vaccine against serogroup B meningococcal disease

Pediatr Infect Dis J. 2013 Apr;32(4):372-3. doi: 10.1097/INF.0b013e318282942f.
No abstract available

MeSH terms

  • Child, Preschool
  • Drug Approval*
  • Europe
  • Female
  • Humans
  • Infant
  • Male
  • Meningococcal Infections / epidemiology*
  • Meningococcal Infections / immunology
  • Meningococcal Infections / prevention & control*
  • Meningococcal Vaccines / administration & dosage
  • Meningococcal Vaccines / immunology*
  • Neisseria meningitidis, Serogroup B / immunology*
  • Vaccination / methods*

Substances

  • 4CMenB vaccine
  • Meningococcal Vaccines